List of Prestalia drug patents

Prestalia is owned by Adhera.

Prestalia contains Amlodipine Besylate; Perindopril Arginine.

Prestalia has a total of 2 drug patents out of which 0 drug patents have expired.

Prestalia was authorised for market use on 21 January, 2015.

Prestalia is available in tablet;oral dosage forms.

Prestalia can be used as treatment of hypertension.

The generics of Prestalia are possible to be released after 05 October, 2029.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6696481 ADHERA Salt of perindopril and pharmaceutical compositions containing it
Apr, 2023

(2 months from now)

US7846961 ADHERA α crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it
Oct, 2029

(6 years from now)

Drugs and Companies using AMLODIPINE BESYLATE; PERINDOPRIL ARGININE ingredient

Market Authorisation Date: 21 January, 2015

Treatment: Treatment of hypertension

Dosage: TABLET;ORAL

How can I launch a generic of PRESTALIA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in